ITIH3 | Inter-alpha-trypsin inhibitor heavy chain 3 | Plasma proteins Predicted secreted proteins
| ![](/images/17373/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17373/51354_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
RTP3 | Receptor (chemosensory) transporter protein 3 | Predicted membrane proteins
| ![](/images/13842/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13842/32367_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
SLC17A1 | Solute carrier family 17 (organic anion transporter), member 1 | Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
SLC22A25 | Solute carrier family 22, member 25 | Predicted membrane proteins Transporters
| ![](/images/39390/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39390/83180_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/10607/25808_B_8_1_rna_selected_60x60.jpg) | Group enriched |
LECT2 | Leukocyte cell-derived chemotaxin 2 | Plasma proteins Predicted secreted proteins
| ![](/images/43883/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43883/125057_A_2_6_rna_selected_60x60.jpg) | Tissue enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | ![](/images/21400/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3781/10124_B_8_6_rna_selected_60x60.jpg) | Group enriched |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/4943/13415_A_2_2_rna_selected_60x60.jpg) | Tissue enriched |
SDS | Serine dehydratase | Enzymes Plasma proteins
| ![](/images/39230/ihc_selected_60x60.jpg) | ![](/images/39230/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39230/85430_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55877/127848_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
VTN | Vitronectin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60933/144159_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
GOLGA6B | Golgin A6 family, member B | | | ![](/images/45056/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/44978/102776_B_8_5_rna_selected_60x60.jpg) | Group enriched |
PGLYRP2 | Peptidoglycan recognition protein 2 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/33468/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33468/79952_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
HEPN1 | Hepatocellular carcinoma, down-regulated 1 | | ![](/images/63054/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63054/141043_B_7_4_rna_selected_60x60.jpg) | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/19551/ihc_cell_selected_60x60.jpg) | ![](/images/19551/127893_B_9_1_rna_selected_60x60.jpg) | Group enriched |
INHBE | Inhibin, beta E | Plasma proteins Predicted secreted proteins
| ![](/images/34017/ihc_selected_60x60.jpg) | ![](/images/16843/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/34017/136520_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
PROZ | Protein Z, vitamin K-dependent plasma glycoprotein | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/16503/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16503/62621_B_8_1_rna_selected_60x60.jpg) | Group enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted secreted proteins
| | ![](/images/38653/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38654/80366_B_7_8_rna_selected_60x60.jpg) | Group enriched |
FMO3 | Flavin containing monooxygenase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images/8065/if_selected_60x60.jpg) | ![](/images/13750/ihc_cell_selected_60x60.jpg) | ![](/images/8065/23618_A_2_3_rna_selected_60x60.jpg) | Tissue enriched |
UGT2A2 | UDP glucuronosyltransferase 2 family, polypeptide A2 | Enzymes Predicted membrane proteins
| ![](/images/45108/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45108/105018_B_9_1_rna_selected_60x60.jpg) | Group enriched |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/16514/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16514/37552_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/19556/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19556/45601_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CYP2B6 | Cytochrome P450, family 2, subfamily B, polypeptide 6 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33866/78284_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/7040/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7040/19610_B_9_1_rna_selected_60x60.jpg) | Group enriched |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3825/11032_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
HSD17B13 | Hydroxysteroid (17-beta) dehydrogenase 13 | | ![](/images/29125/ihc_selected_60x60.jpg) | ![](/images/29125/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/29125/69598_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
MAT1A | Methionine adenosyltransferase I, alpha | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48627/110759_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
UPB1 | Ureidopropionase, beta | Disease related genes Enzymes Potential drug targets
| ![](/images/728/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/728/1801_B_8_6_rna_selected_60x60.jpg) | Group enriched |
CPB2 | Carboxypeptidase B2 (plasma) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/4146/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4146/12401_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
MASP2 | Mannan-binding lectin serine peptidase 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| ![](/images/29313/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/29313/72651_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Enzymes
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4860/14118_B_8_6_rna_selected_60x60.jpg) | Group enriched |
ALB | Albumin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6262/17726_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ANG | Angiogenin, ribonuclease, RNase A family, 5 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
CYP26A1 | Cytochrome P450, family 26, subfamily A, polypeptide 1 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
GC | Group-specific component (vitamin D binding protein) | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/1526/ihc_cell_selected_60x60.jpg) | ![](/images/1526/4387_B_7_3_rna_selected_60x60.jpg) | Group enriched |
SLC13A5 | Solute carrier family 13 (sodium-dependent citrate transporter), member 5 | Predicted membrane proteins Transporters
| ![](/images/44343/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44343/97195_B_9_2_rna_selected_60x60.jpg) | Group enriched |
AC137056.1 | Uncharacterized protein; cDNA FLJ34659 fis, clone KIDNE2018863 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
ACOT12 | Acyl-CoA thioesterase 12 | Enzymes Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37723/82494_B_9_8_rna_selected_60x60.jpg) | Tissue enriched |
AGXT2 | Alanine--glyoxylate aminotransferase 2 | Enzymes Mitochondrial proteins
| ![](/images/37382/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37382/79555_B_9_1_rna_selected_60x60.jpg) | Group enriched |
DIO1 | Deiodinase, iodothyronine, type I | Enzymes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
GYS2 | Glycogen synthase 2 (liver) | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| ![](/images/39482/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39482/86435_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
C5 | Complement component 5 | Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images/29339/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29339/64473_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
ITIH4 | Inter-alpha-trypsin inhibitor heavy chain family, member 4 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/1835/ihc_cell_selected_60x60.jpg) | ![](/images/1835/7355_B_8_8_rna_selected_60x60.jpg) | Tissue enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | ![](/images/243/ihc_cell_selected_60x60.jpg) | ![](/images/243/579_A_2_4_rna_selected_60x60.jpg) | Group enriched |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/53294/ihc_cell_selected_60x60.jpg) | ![](/images/53294/125385_B_2_6_rna_selected_60x60.jpg) | Tissue enriched |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8591/22285_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
AMBP | Alpha-1-microglobulin/bikunin precursor | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1497/6975_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
ASGR1 | Asialoglycoprotein receptor 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12852/41334_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
CYP8B1 | Cytochrome P450, family 8, subfamily B, polypeptide 1 | Enzymes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |